Mixed results for arthritis drug repurposed as Covid-19 treatment

Tocilizumab has been used by doctors since the start of the pandemic with the hope of tamping down an abnormal immune response known as a "cytokine storm" that causes severe organ damage in some hospitalised Covid-19 patients.

Mixed results for arthritis drug repurposed as Covid-19 treatment
Tocilizumab has been used by doctors since the start of the pandemic with the hope of tamping down an abnormal immune response known as a "cytokine storm" that causes severe organ damage in some hospitalised Covid-19 patients.